| Literature DB >> 33478628 |
Yonit Tavor1, Moshe Herskovitz2,3, Galia Ronen4, Alexandra Balbir-Gurman1,2.
Abstract
Transverse myelitis is an inflammatory lesion of the spinal cord, occurring in different autoimmune, infectious, and traumatic diseases but is the hallmark of neuromyelitis optica (NMO), a rare neurologic autoimmune disease. Patients with systemic lupus erythematosus (SLE) may develop transverse myelitis as a neuropsychiatric complication of active disease; however, at times, NMO co-exists as an additional primary autoimmune condition in a SLE patient. Correct diagnosis of a SLE-NMO overlap is important not only for the different disease course and prognosis compared with SLE-related LETM, but especially for the emerging and highly specific NMO treatment options, not established for SLE-related LETM-such as anti-aquaporin 4 antibodies, anti-VEGF antibodies, complement modulation, or IVIg.Entities:
Year: 2021 PMID: 33478628 PMCID: PMC7835116 DOI: 10.5041/RMMJ.10429
Source DB: PubMed Journal: Rambam Maimonides Med J ISSN: 2076-9172